BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19722276)

  • 1. Rapid response to therapy of neurocutaneous melanosis with leptomeningeal melanoma.
    Subbiah V; Wolff JE
    Pediatr Blood Cancer; 2010 Jan; 54(1):180-1. PubMed ID: 19722276
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurocutaneous Melanocytosis and Leptomeningeal Melanoma.
    Mitre V; Heym K; Clark GD; Venkatramani R
    J Pediatr Hematol Oncol; 2021 Mar; 43(2):e195-e197. PubMed ID: 31764519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal leptomeningeal melanoma in neurocutaneous melanosis.
    Furtado S; Furtado SV; Ghosal N; Hegde AS
    Pediatr Dermatol; 2012; 29(3):358-61. PubMed ID: 21906139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mystery Case: Neurocutaneous melanosis with diffuse leptomeningeal malignant melanoma in an adult.
    Bhatia R; Kataria V; Vibha D; Kakkar A; Prasad K; Mathur S; Garg A; Bakhshi S
    Neurology; 2016 Feb; 86(8):e75-9. PubMed ID: 26903493
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurocutaneous melanosis associated with malignant leptomeningeal melanoma in an adult: clinical significance of 5-S-cysteinyldopa in the cerebrospinal fluid---case report.
    Shinno K; Nagahiro S; Uno M; Kannuki S; Nakaiso M; Sano N; Horiguchi H
    Neurol Med Chir (Tokyo); 2003 Dec; 43(12):619-25. PubMed ID: 14723271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new variety of neurocutaneous melanosis: benign leptomeningeal melanocytoma associated with extensive Mongolian spot on the back].
    Kawara S; Takata M; Hirone T; Tomita K; Hamaoka H
    Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(5):561-6. PubMed ID: 2585771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AN 11-Year-Old Boy with a Leptomeningeal Tumor.
    Habougit C; Forest F; Boutet C; Douchet C; Stephan JL; Stachowicz ML; Vassal F; Péoc'h M
    Brain Pathol; 2017 Jul; 27(4):553-554. PubMed ID: 28585389
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary temporal melanoma without diffuse leptomeningeal involvement: a variant of neurocutaneous melanosis.
    Eaves FF; Burstein FD; Hudgins R; Cohen SR; Papciack M
    Plast Reconstr Surg; 1995 Jan; 95(1):133-5. PubMed ID: 7809226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocutaneous melanosis with leptomeningeal melanoma.
    Akinwunmi J; Sgouros S; Moss C; Grundy R; Green S
    Pediatr Neurosurg; 2001 Nov; 35(5):277-9. PubMed ID: 11741125
    [No Abstract]   [Full Text] [Related]  

  • 10. [News on melanoma from the 2010 Dermatology Days in Paris].
    Boulinguez S
    Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H16-20. PubMed ID: 21703460
    [No Abstract]   [Full Text] [Related]  

  • 11. Neurocutaneous melanosis.
    Di Rocco F; Sabatino G; Koutzoglou M; Battaglia D; Caldarelli M; Tamburrini G
    Childs Nerv Syst; 2004 Jan; 20(1):23-8. PubMed ID: 14576958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocutaneous melanosis associated with autoimmune diabetes mellitus.
    Joseph KR; Difazio MP; Hartman KR; Ney JP
    Neurology; 2007 May; 68(21):1862-3. PubMed ID: 17515550
    [No Abstract]   [Full Text] [Related]  

  • 13. Large primary meningeal melanoma in an adult patient with neurocutaneous melanosis.
    Kiecker F; Hofmann MA; Audring H; Brenner A; Labitzke C; Sterry W; Trefzer U
    Clin Neurol Neurosurg; 2007 Jun; 109(5):448-51. PubMed ID: 17382464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of leptomeningeal disease.
    Walker JG
    Clin J Oncol Nurs; 2009 Aug; 13(4):384-7. PubMed ID: 19648093
    [No Abstract]   [Full Text] [Related]  

  • 15. Rare presentation in an adult patient with neurocutaneous melanosis.
    Ge P; Wang H; Zhong Y; Chen B; Ling F; Luo Y
    Int J Dermatol; 2010 Nov; 49(11):1311-3. PubMed ID: 20964655
    [No Abstract]   [Full Text] [Related]  

  • 16. CSF cytology diagnosis of NRAS-mutated primary leptomeningeal melanomatosis with neurocutaneous melanosis.
    Kolin DL; Geddie WR; Ko HM
    Cytopathology; 2017 Jun; 28(3):235-238. PubMed ID: 27696542
    [No Abstract]   [Full Text] [Related]  

  • 17. Leptomeningeal melanomatosis associated with neurocutaneous melanosis: an autopsy case report.
    Matsumura M; Okudela K; Tateishi Y; Umeda S; Mitsui H; Suzuki T; Nakayama T; Inayama Y; Ohashi K
    Pathol Int; 2015 Feb; 65(2):100-5. PubMed ID: 25521302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocutaneous melanosis: follow-up and literature review.
    Scattolin MA; Lin J; Peruchi MM; Rocha AJ; Masruha MR; Vilanova LC
    J Neuroradiol; 2011 Dec; 38(5):313-8. PubMed ID: 21489630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I and open-label phase II studies.
    Eisen T; Marais R; Affolter A; Lorigan P; Robert C; Corrie P; Ottensmeier C; Chevreau C; Chao D; Nathan PD; Jouary T; Harries M; Negrier S; Montegriffo E; Ahmad T; Gibbens I; James MG; Strauss UP; Prendergast S; Gore ME
    Br J Cancer; 2011 Jul; 105(3):353-9. PubMed ID: 21750549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital Melanocytic Nevi Syndrome With Leptomeningeal Melanoma.
    Mohite A; Agrawal A; Purandare N; Shah S; Puranik A; Choudhury S; Dev I; Ghosh S; Rangarajan V
    Clin Nucl Med; 2022 Dec; 47(12):e765-e766. PubMed ID: 35867990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.